Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated:  12/21/2015
Clinical Research Facility
mi
from
Rocky Mount, NC
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated: 12/21/2015
Clinical Research Facility
mi
from
Rocky Mount, NC
Click here to add this to my saved trials
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated:  12/21/2015
Clinical Research Facility
mi
from
Wilmington, NC
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated: 12/21/2015
Clinical Research Facility
mi
from
Wilmington, NC
Click here to add this to my saved trials
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated:  12/21/2015
Clinical Research Facility
mi
from
Winston-Salem, NC
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated: 12/21/2015
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated:  12/21/2015
Clinical Research Facility
mi
from
Beachwood, OH
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated: 12/21/2015
Clinical Research Facility
mi
from
Beachwood, OH
Click here to add this to my saved trials
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated:  12/21/2015
Clinical Research Facility
mi
from
Canton, OH
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated: 12/21/2015
Clinical Research Facility
mi
from
Canton, OH
Click here to add this to my saved trials
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated:  12/21/2015
Clinical Research Facility
mi
from
Cleveland, OH
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated: 12/21/2015
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated:  12/21/2015
Clinical Research Facility
mi
from
Tulsa, OK
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated: 12/21/2015
Clinical Research Facility
mi
from
Tulsa, OK
Click here to add this to my saved trials
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated:  12/21/2015
Clinical Research Facility
mi
from
Portland, OR
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated: 12/21/2015
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated:  12/21/2015
Clinical Research Facility
mi
from
Springfield, OR
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated: 12/21/2015
Clinical Research Facility
mi
from
Springfield, OR
Click here to add this to my saved trials
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated:  12/21/2015
Clinical Research Facility
mi
from
Altoona, PA
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated: 12/21/2015
Clinical Research Facility
mi
from
Altoona, PA
Click here to add this to my saved trials
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated:  12/21/2015
Clinical Research Facility
mi
from
Philadelphia, PA
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated: 12/21/2015
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated:  12/21/2015
Clinical Research Facility
mi
from
Pittsburgh, PA
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated: 12/21/2015
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated:  12/21/2015
Clinical Research Facility
mi
from
Sayre, PA
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated: 12/21/2015
Clinical Research Facility
mi
from
Sayre, PA
Click here to add this to my saved trials
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated:  12/21/2015
Clinical Research Facility
mi
from
Charleston, SC
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated: 12/21/2015
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated:  12/21/2015
Clinical Research Facility
mi
from
Sioux Falls, SD
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated: 12/21/2015
Clinical Research Facility
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated:  12/21/2015
Clinical Research Facility
mi
from
Chattanooga, TN
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated: 12/21/2015
Clinical Research Facility
mi
from
Chattanooga, TN
Click here to add this to my saved trials
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated:  12/21/2015
Clinical Research Facility
mi
from
Germantown, TN
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated: 12/21/2015
Clinical Research Facility
mi
from
Germantown, TN
Click here to add this to my saved trials
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated:  12/21/2015
Clinical Research Facility
mi
from
Houston, TX
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated: 12/21/2015
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated:  12/21/2015
Clinical Research Facility
mi
from
Plano, TX
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated: 12/21/2015
Clinical Research Facility
mi
from
Plano, TX
Click here to add this to my saved trials
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated:  12/21/2015
Clinical Research Facility
mi
from
Salt Lake City, UT
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated: 12/21/2015
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated:  12/21/2015
Site Reference ID/Investigator# 6726
mi
from
Charlettesville, VA
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated: 12/21/2015
Site Reference ID/Investigator# 6726
mi
from
Charlettesville, VA
Click here to add this to my saved trials
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated:  12/21/2015
Clinical Research Facility
mi
from
Fairfax, VA
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated: 12/21/2015
Clinical Research Facility
mi
from
Fairfax, VA
Click here to add this to my saved trials
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated:  12/21/2015
Clinical Research Facility
mi
from
Richmond, VA
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated: 12/21/2015
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated:  12/21/2015
Clinical Research Facility
mi
from
Seattle, WA
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated: 12/21/2015
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated:  12/21/2015
Clinical Research Facility
mi
from
Spokane, WA
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated: 12/21/2015
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated:  12/21/2015
Clinical Research Facility
mi
from
Tacoma, WA
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated: 12/21/2015
Clinical Research Facility
mi
from
Tacoma, WA
Click here to add this to my saved trials
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated:  12/21/2015
Clinical Research Facility
mi
from
Madison, WI
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated: 12/21/2015
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated:  12/21/2015
Clinical Research Facility
mi
from
Milwaukee, WI
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated: 12/21/2015
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated:  12/21/2015
Clinical Research Facility
mi
from
Summit, WI
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated: 12/21/2015
Clinical Research Facility
mi
from
Summit, WI
Click here to add this to my saved trials
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated:  12/21/2015
Clinical Research Facility
mi
from
West Bend, WI
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated: 12/21/2015
Clinical Research Facility
mi
from
West Bend, WI
Click here to add this to my saved trials
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated:  12/21/2015
mi
from
Adelaide,
A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling
Updated: 12/21/2015
mi
from
Adelaide,
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  12/21/2015
The Birmingham Pain Center
mi
from
Birmingham, AL
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 12/21/2015
The Birmingham Pain Center
mi
from
Birmingham, AL
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  12/21/2015
Simon Williamson Clinic, PC
mi
from
Hueytown, AL
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 12/21/2015
Simon Williamson Clinic, PC
mi
from
Hueytown, AL
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  12/21/2015
Alabama Orthopedic Clinic
mi
from
Mobile, AL
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 12/21/2015
Alabama Orthopedic Clinic
mi
from
Mobile, AL
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  12/21/2015
Clinical Research Advantage, Inc./ Mesa Family Medical Center
mi
from
Mesa, AZ
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 12/21/2015
Clinical Research Advantage, Inc./ Mesa Family Medical Center
mi
from
Mesa, AZ
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  12/21/2015
Clinical Research Advantage, Inc.
mi
from
Tempe, AZ
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 12/21/2015
Clinical Research Advantage, Inc.
mi
from
Tempe, AZ
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  12/21/2015
Harmony Clinical Research, Inc.
mi
from
Tucson, AZ
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 12/21/2015
Harmony Clinical Research, Inc.
mi
from
Tucson, AZ
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  12/21/2015
Verona Clinical Research, Inc.
mi
from
Tucson, AZ
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 12/21/2015
Verona Clinical Research, Inc.
mi
from
Tucson, AZ
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  12/21/2015
Quality of Life Medical and Research Center
mi
from
Tucson, AZ
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 12/21/2015
Quality of Life Medical and Research Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  12/21/2015
Pusch Ridge Family Medicine / WC Clinical Research
mi
from
Tucson, AZ
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 12/21/2015
Pusch Ridge Family Medicine / WC Clinical Research
mi
from
Tucson, AZ
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  12/21/2015
Genova Clinical Research, Inc.
mi
from
Tuscon, AZ
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 12/21/2015
Genova Clinical Research, Inc.
mi
from
Tuscon, AZ
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  12/21/2015
Advanced Clinical Research Institute
mi
from
Anaheim, CA
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 12/21/2015
Advanced Clinical Research Institute
mi
from
Anaheim, CA
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  12/21/2015
Orange County Clinical Trials, Inc.
mi
from
Anaheim, CA
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 12/21/2015
Orange County Clinical Trials, Inc.
mi
from
Anaheim, CA
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  12/21/2015
Gregory J. Wiener, MD PC
mi
from
Chula Vista, CA
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 12/21/2015
Gregory J. Wiener, MD PC
mi
from
Chula Vista, CA
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  12/21/2015
Digestive & Liver Disease Specialists
mi
from
Garden Grove, CA
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 12/21/2015
Digestive & Liver Disease Specialists
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  12/21/2015
Rx Clinical Research, Inc.
mi
from
Garden Grove, CA
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 12/21/2015
Rx Clinical Research, Inc.
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  12/21/2015
Physicians Clinical Research Corporation
mi
from
Laguna Hills, CA
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 12/21/2015
Physicians Clinical Research Corporation
mi
from
Laguna Hills, CA
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  12/21/2015
Loma Linda University Physicians Medical Group
mi
from
Loma Linda, CA
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 12/21/2015
Loma Linda University Physicians Medical Group
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  12/21/2015
HealthCare Partners Medical Group
mi
from
Long Beach, CA
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 12/21/2015
HealthCare Partners Medical Group
mi
from
Long Beach, CA
Click here to add this to my saved trials
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated:  12/21/2015
Impact Clinical Trials
mi
from
Los Angeles, CA
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
A Multi-center, Randomized, Double-Blinded Study of the Efficacy and Safety of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction (OBD)
Status: Enrolling
Updated: 12/21/2015
Impact Clinical Trials
mi
from
Los Angeles, CA
Click here to add this to my saved trials